Kingsbury Capital Investment Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$224K Buy
19,909
+17,517
+732% +$220K 0.34% 58
2022
Q2
$33K Buy
2,392
+883
+59% +$20.7K 0.05% 90
2022
Q1
$78K Buy
+1,509
New +$66.7K 0.09% 89

Other funds holding MTEM

Kingsbury Capital Investment Advisors's MTEM Position: Q3 2022 in Review

Kingsbury Capital Investment Advisors increased its Molecular Templates, Inc. (MTEM) stake by 732% in Q3 2022, buying an estimated $220K and bringing the position to 19,909 shares worth $224K. The position accounts for 0.34% of the portfolio, ranked #58.

Kingsbury Capital Investment Advisors first reported a position in MTEM in Q1 2022 and has held it in 3 quarters since. 58 funds tracked by Wall St. Rank hold MTEM as of Q3 2022.

  • Kingsbury Capital Investment Advisors held 19,909 shares of Molecular Templates, Inc. worth $224K as of Q3 2022.
  • Kingsbury Capital Investment Advisors bought 17,517 Molecular Templates, Inc. shares in Q3 2022, an estimated $220K.
  • Molecular Templates, Inc. made up 0.34% of Kingsbury Capital Investment Advisors's portfolio in Q3 2022, its #58 holding.
  • Kingsbury Capital Investment Advisors first reported a position in Molecular Templates, Inc. in Q1 2022 and has held it in 3 quarters since.
  • 58 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2022.

Based on Kingsbury Capital Investment Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.